The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia

Xenophon Kassianides; Adil Mohammad Hazara; Iain C Macdougall; Philip A Kalra; Sunil Bhandari

doi:10.1016/j.ekir.2021.11.002

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia

Kidney Int Rep. 2021 Nov 24;7(2):322-326. doi: 10.1016/j.ekir.2021.11.002. eCollection 2022 Feb.

Authors

Xenophon Kassianides¹, Adil Mohammad Hazara¹, Iain C Macdougall², Philip A Kalra³, Sunil Bhandari¹

Affiliations

¹ Academic Renal Research Department, Hull University Teaching Hospitals NHS Trust and Hull York Medical School, Hull, UK.
² Department of Renal Medicine, King's College Hospital, London, UK.
³ Department of Renal Medicine, Salford Royal NHS Foundation Trust and University of Manchester, Manchester, UK.

No abstract available

Keywords: chronic kidney disease; cystatin C; ferric derisomaltose; intravenous iron; iron deficiency; neutrophil gelatinase associated lipocalin.